Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.

Antimicrobial Agents and Chemotherapy
Katie SaxtonMark H Wilcox

Abstract

The incidence of Clostridium difficile infection is increasing, with reports implicating fluoroquinolone use. A three-stage chemostat gut model was used to study the effects of three fluoroquinolones (ciprofloxacin, levofloxacin, and moxifloxacin) on the gut microbiota and two epidemic C. difficile strains, strains of PCR ribotypes 027 and 001, in separate experiments. C. difficile total viable counts, spore counts, and cytotoxin titers were determined. The emergence of C. difficile isolates with reduced antibiotic susceptibility was monitored with fluoroquinolone-containing medium, and molecular analysis of the quinolone resistance-determining region was performed. C. difficile spores were quiescent in the absence of fluoroquinolones. Instillation of each fluoroquinolone led to C. difficile spore germination and high-level cytotoxin production. High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and moxifloxacin, in which marked cytotoxin production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium. Three C. difficile PCR ribotype 027 isolates and one C. difficile PCR ribotype 001 iso...Continue Reading

References

Dec 1, 1988·Antimicrobial Agents and Chemotherapy·C EdlundC E Nord
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·N X Chin, H C Neu
Dec 1, 1984·Journal of Medical Microbiology·J M KetleyD W Burdon
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·E M Veringa, D van der Waaij
Jan 1, 1997·Scandinavian Journal of Infectious Diseases·C EdlundC E Nord
Oct 20, 1998·The Journal of Hospital Infection·G E Bignardi
Dec 22, 1999·Microbes and Infection·J Freeman, M H Wilcox
Feb 10, 2000·The New England Journal of Medicine·L KyneC P Kelly
Mar 15, 2000·Scandinavian Journal of Infectious Diseases·C EdlundC E Nord
May 5, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G AckermannA C Rodloff
Jan 11, 2001·The Journal of Antimicrobial Chemotherapy·J WiströmB Svenungsson
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David C. Hooper
Dec 6, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·C YipJ Olde
Mar 2, 2002·The Lancet Infectious Diseases·A SullivanC E Nord
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Larbi DridiJean-Claude Petit
Jun 26, 2003·Nucleic Acids Research·Ramu ChennaJulie D Thompson
Jul 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Oh, C Edlund
Jul 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G AckermannS H Cohen
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert GaynesFred C Tenover
Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·L DridiJ-C Petit
Apr 16, 2005·Clinical Microbiology Reviews·Daniel E Voth, Jimmy D Ballard
Apr 30, 2005·The Journal of Antimicrobial Chemotherapy·Simon D BainesMark H Wilcox
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Nicole J Pultz, Curtis J Donskey
Sep 13, 2005·The Lancet Infectious Diseases·Rob Brierley
Sep 24, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jacques PépinBenoit Cossette
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacques PépinLuc Lanthier
Dec 3, 2005·The New England Journal of Medicine·L Clifford McDonaldDale N Gerding
Feb 1, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Priscilla BillerL Clifford McDonald
Jun 8, 2007·Emerging Infectious Diseases·Denise DrudySéamus Fanning
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louis ValiquetteJacques Pépin

❮ Previous
Next ❯

Citations

Sep 14, 2010·Journal of Industrial Microbiology & Biotechnology·Alan T Bull
Jun 17, 2010·The Journal of Antibiotics·Stefano DonadioDaniela Jabes
Jun 17, 2009·Nature Reviews. Microbiology·Maja RupnikDale N Gerding
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Simon D BainesMark H Wilcox
May 29, 2008·Future Microbiology·Jared Crandon, David P Nicolau
Jun 21, 2011·Annual Review of Microbiology·Karen C Carroll, John G Bartlett
Dec 21, 2012·Expert Review of Anti-infective Therapy·Matteo BassettiMark Wilcox
Jan 14, 2016·The Journal of Antimicrobial Chemotherapy·C H ChiltonT M Monaghan
Jul 15, 2009·International Journal of Antimicrobial Agents·Mark H Wilcox
Jul 18, 2009·International Journal of Antimicrobial Agents·C DenèveA Collignon
May 1, 2015·The Journal of Antimicrobial Chemotherapy·Grace S CrowtherMark H Wilcox
Sep 25, 2010·Research in Microbiology·David A BurnsNigel P Minton
May 5, 2012·Gut Microbes·Emma L BestMark H Wilcox
Jan 15, 2015·Infectious Disease Clinics of North America·Caroline H Chilton, Jane Freeman
Jul 27, 2017·International Wound Journal·Sharon LindsayKatie Bourdillon
Feb 23, 2013·Journal of Medical Microbiology·Michael John AldapeDennis Leroy Stevens
Dec 28, 2018·The Journal of Antimicrobial Chemotherapy·J J VernonJ Freeman
Sep 16, 2020·The Journal of Antimicrobial Chemotherapy·Anthony M BuckleyMark H Wilcox
Feb 7, 2021·NPJ Biofilms and Microbiomes·Charmaine NormingtonAnthony M Buckley
Sep 9, 2009·Indian Journal of Medical Microbiology·C Vaishnavi
Apr 11, 2021·The Journal of Infectious Diseases·C M RooneyM H Wilcox

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved